Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

about

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

Item

http://www.wikidata.org/entity/Q55030699

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@en

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@nl

type

Item

label

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@en

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@nl

prefLabel

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@en

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@nl

P1476

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

@en

P2093

Eiji Kubota

http://www.w3.org/2001/XMLSchema#string

Hiromi Kataoka

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Koyama

http://www.w3.org/2001/XMLSchema#string

Kenro Imaeda

http://www.w3.org/2001/XMLSchema#string

Takashi Joh

http://www.w3.org/2001/XMLSchema#string

Takashi Yagi

http://www.w3.org/2001/XMLSchema#string

Tomohiro Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

NIH Image to ImageJ: 25 years of image analysis

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies

Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase

MAP kinase genes and colon and rectal cancer.

Contribute data to the 6th edition of the IDF Diabetes Atlas.

CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

P304

10650-10664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24367

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535833

http://www.w3.org/2001/XMLSchema#string

P932

5828215

http://www.w3.org/2001/XMLSchema#string